Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-25-280127·LifeStance Health Group, Inc.
Schedule 13G ownership disclosure
LifeStance Health Group Inc
Common Stock, par value $0.01 per share · CUSIP: 53228F101
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Summit Partners, L.P.
Shares: 33,524,715 · Class: 8.62%
- Summit Partners Growth Equity Fund IX-A, L.P.
Shares: 20,529,149 · Class: 5.28%
- Summit Partners Growth Equity Fund IX-B, L.P.
Shares: 12,818,117 · Class: 3.30%
- Summit Investors GE IX/VC IV (UK), L.P.
Shares: 14,991 · Class: 0.01%
- Summit Partners Entrepreneur Advisors Fund II, L.P.
Shares: 19,157 · Class: 0.01%
- Summit Investors GE IX/VC IV, LLC
Shares: 143,301 · Class: 0.04%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-280127
- Form type
- SCHEDULE 13G/A
- Filer
- LifeStance Health Group, Inc.
- CIK
- CIK 1845257
- Filed
- Nov 13, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership